Gian Lifecare Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Gian Lifecare Ltd is ₹ 4.2 as of 23 Oct 15:30 . The P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 17.77 crore on March 2025 . This represents a CAGR of -19.81% over 4 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Gian Lifecare Ltd for the Dec '25 is ₹ 1.21 crore as compare to the Sep '25 revenue of ₹ 0.75 crore. This represent the growth of 61.33% The revenue of Global Longlife Hospital and Research Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gian Lifecare Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ -0.32 crore. This represent the decline of -203% The ebitda of Global Longlife Hospital and Research Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gian Lifecare Ltd changed from ₹ 0.09 crore to ₹ 0.1 crore over 7 quarters. This represents a CAGR of 6.21% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Gian Lifecare Ltd

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
March 01, 2019. Company is a fast growing professionally managed organization with an ultra-modem fully integrated, manufacturing facility dedicated to provide diagnostic services.
It established the organization in 2018.
Gian' is committed to Quality services that address the prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The diagnostic center under the name of 'M/s.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Gian Lifecare Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Gian Lifecare Ltd is 4 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd?

As of October 25, 2026, the Gian Lifecare Ltd stock price is INR ₹4.2. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.57.

How do dividend payouts of Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Gian Lifecare Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.